To provide more detailed information about Candida epidemiology and pathogenesis in pediatric burn patients, Candida isolates from 113 patients collected over 3 years were identified at the species level and the serotypes and biotypes of the C. albicans isolates were determined. A total of 85% of the patients were colonized or infected by C. albicans, 18% by C. tropicalis, and 11% by C. parapsilosis. Although colonization or infection often was found at multiple sites and times, 87% of the patients were colonized or infected by only one Candida species or strain; the other 13% showed multiple colonizations or infections, some of which occurred simultaneously at the same site. C. albicans biotyping determined the tolerance of the isolates to pH (pH 1.4) and sait; flucytosine, borate, and safranine resistance; and ability to produce proteinase and assimilate urea, sorbose, and citrate; results are expressed as three-digit numbers. For isolates from three different anatomical sites, the distribution of the nine biotype characteristics was similar in all cases but one. Significantly more fecal than wound or throat isolates were resistant to safranine. Sixty-four different serotype-biotype combinations were found in the 96 patients with C. albicans infections or colonizations. Twenty-nine percent of ail C. albicans isolates had the partial biotype -57, whiie 20 of the 96 patients had specifically serotype B, biotype 557 colonizations or infections. Eleven patients had the B557 infection when admitted; nine patients acquired the yeast in-house. Thirty percent of the C. albicans isolated from 23 adult patients at a nearby hospital also showed the -57 biotype pattern, suggesting that C. albicans isolates expressing this biotype are either extremely prevalent in nature or are more virulent than other C. albicans isolates.
Several Candida species are secondary pathogens which, with the use of topical and systemic antibiotics to suppress bacteria, have become reponsible for a growing number of deaths in burn patients (1, 5, 6, 9, 16, 23) . While these fungi are often cultured from burn wounds and are frequently innocuous, there are times when Candida infection becomes invasive and life-threatening. Spebar and Pruitt (23) have reported that of 172 patients with Candida colonization of the eschar, only 20.7% subsequently developed invasive candidal sepsis. However, once fungal sepsis occurs in burn patients, over 90% of these individuals die (1, 16, 23) . To combat the high mortality, prevention of the invasive stage of infection by expeditious closure of the burn wound has been suggested (16, 23) , and treatment with antifungal agents has been used (4) (5) (6) 16) . However, the systemic antifungal agents themselves are toxic to the patient (4, 6) . Hence, Candida sepsis continues to persist as a significant problem for burn (16) and other immunocompromised (2, 5, 9, 17) patients.
Since candidiasis is so difficult to treat, an active program of prevention of the infection may be an effective way to attack this disease. The formulation of such a program, however, requires detailed information about Candida pathogenesis and epidemiology in burn patients (17) . Information about C. albicans would be of prime importance, since this species is the one most often cultured from burn patients (1) and, in general, is considered to be the most virulent (11) . Until recently, however, detailed study of the sources, modes of transmission, and types of C. albicans in the causation of candidiasis has not been possible because of the absence of a method for fine subdivision of strains within the species; hence, one C. albicans could not be distin- * (12); hence, for the drawing of conclusions in this study, isolates were considered different only if they differed in three or more of the biotyping tests or if they had different serotypes. For biotyping, the isolates were coded, run blindly in triplicate on the nine test plates in three batches, and interpreted by the same person.
C. albicans serotypes were distinguished on the basis of reactions of agglutination (serotype A) or nonagglutination (serotype B) with Candida-check antiserum 6 patronn Inc., Tokyo, Japan). All serotyping was also done blindly.
Statistical analyses. Significance of differences in the number of isolates showing a certain biotype characteristic was determined by 2 by 2 chi-square tests with Yates correction for continuity (21) . Differences were considered significant at P < 0.05.
RESULTS
Three different Candida species were isolated from the 113 pediatric burn patients. The number of patients with single or multiple Candida species colonizations are listed in patients, different Candida species occurred at the same time and sometimes even at the same site (Table 2 , patients B and C). In one case, C. albicans, C. tropicalis, and C. parapsilosis were isolated from the same patient at the same time (Table 2 , patient C). Serotypes of 157 C. albicans isolates from 96 pediatric burn patients were determined; 105 isolates were serotype A and 52 were serotype B. For 31 of the 96 patients colonized by C. albicans, more than one C. albicans culture was obtained. For 28 of these patients, the same C. albicans, by our criteria, was found repeatedly, as illustrated by patient D (Table 2) . For three patients, however, more than one C. albicans was isolated, sometimes even from the same site, as exemplified by patient E (Table 2 ) who, on 10 March 1986, had both a serotype A, biotype 317 C. albicans and a serotype B, biotype 577 C. albicans isolated from his throat.
A total of 64 different serotype-biotype number combinations were found in the isolates from the 96 pediatric burn patients (Table 3) . Over one-half (50%) of the serotypebiotype combinations appeared only once. A total of 29% of infections, 11 were admitted to the hospital with the infection, while 9 patients acquired the yeast after admission.
The results of individual biotyping tests performed on isolates from throats, wounds, or stools of pediatric burn patients are compared in Table 4 . With the exception of safranine resistance, any single biotype characteristic was quite consistent from one isolation site to another. Safranine was significantly more inhibitory to isolates from wounds and throats than it was to isolates from stools.
To determine whether the serotyping-biotyping patterns of isolates from these pediatric burn patients differed significantly from the patterns of isolates from patients in the local adult nonburn population, biotypes of 27 isolates from 23 adult patients at another local hospital were determined. Of these isolates, 14 were serotype A and 13 were serotype B. Twenty-one different serotype-biotype combinations were found; 30% of these isolates had the -57 biotype pattern (Table 5) `. When results for individual biotype characteristics between the two patient populations were compared, isolates from both populations were found to be very similar, except for their citrate assimilation test results (Table 6) . Significantly more isolates from the pediatric burn patients could assimilate citrate than could isolates from the adult nonburn patient population.
DISCUSSION
A total of 64 different serotype-biotype number combinations were found among the 96 pediatric burn patients (Table  3) , and 19 were found among the 23 adult nonburn patients (Table 5 ). For both the pediatric burn and the adult patients, serotype B correlated with flucytosine resistance (a score of 4 or more in the first set of biotype tests). These findings are in agreement with those of a study of C. albicans phenotypes in which a more general patient population was used (14) .
Comparison of the nine individual biotyping test results for
isolates from these two patient populations showed a remarkable similarity in the percentage of isolates with any one characteristic (Table 6 ). For one of the tests, however, the results were significantly different. A total of 98% of the isolates from the burn patients assimilated citrate, while significantly fewer (74%) isolates from the adult nonburned group grew on this carbon source. While these results only apply to the 128 pediatric burn isolates studied, two studies by Odds and Abbott (12, 13) showed that 70% of 92 isolates (12) and 76% of 50 isolates (13) from mixed patient populations assimilated citrate. Hence, although the adult nonburn population in this study was small, the results for citrate assimilation in this group agreed well with those of studies of citrate metabolism by isolates from other patient populations. Why more of the C. albicans from the burn patients could utilize citrate as their sole carbon source is not known; however, an investigation of this phenomenon might provide some clues to Candida pathogenesis in burn patients.
Nearly 30% of the pediatric burn patient isolates had the same partial biotype, -57. The finding that this partial biotype (15) .
In the majority ofthe burn patients with the -57 test result, strains were specifically serotype B, biotype 557. They therefore differed in serotype from the -57 strains studied previously (3, 8) . Isolates with this biotype grew in al three resistance tests and were resistant to all substances tested in the biotyping series. One might speculate that such resistance properties could cause these strains to be more virulent, or at least to persist longer, and therefore be found more frequently. One result of the resistance testing which was unexpected, however, was the finding of a higher percentage of stool versus throat or wound isolates which were resistant to safranine (Table 4) . Why more isolates from this site could survive in the presence of this dye is unclear, but it may be worth investigating, especially since the gastrointestinal tract has been implicated as a primary portal of entry for systemic candidiases (24) .
The finding of 20 of 96 patients ( Table 1 ) or by more than one strain of the same Candida species (3 of 31 patients from whom multiple C. albicans cultures were taken). The finding that a patient can be colonized or infected by more than one strain of an organism is not new. By using the system of Odds and Abbott (12) , O'Connor and Sobel (10) found that 20% of 35 rectal C. albicans isolates were different from vaginal isolates in the same patients. Warnock et al. (26) , using a resistogram system of typing, reported that 14 of 30 patients had different oral than vaginal C. albicans. Different strains of bacteria, for example, Pseudomonas aeruginosa, have been found to occur simultaneously in hospitalized patients, in general (19) , and in cystic fibrosis (25) and burn (7) patients, in particular. The occurrence of cocolonization may explain treatment failures, especially when single antimicrobial agents are used. For example, patient B (Table 2) had C. albicans stool colonization with C. albicans biotypes 104 and 557. Since most isolates of susceptible yeasts are inhibited by 8 p.g or less of flucytosine per ml and are killed by 16 ,ug or less per ml (18) , treatment of this patient with flucytosine might eliminate C. albicans biotype 104, which the biotype screening with 25 ,ug of flucytosine per ml suggests is susceptible to this common antifungal agent. However, this treatment would not eliminate the biotype 557 strain, which, from results of the biotyping test, was found to be resistant to this agent. Hence, treatment of this patient with this antifungal agent would not be successful, because at best only one of the C. albicans would be affected. As more antifungal agents become available, the ability of the laboratory to define the number and characteristics of the infecting fungi may become more important in helping the clinician to choose the best agent or combination of agents to successfully treat all Candida infections in any one patient.
